Engineering and quality transformation at scale
From regulated medical-device automation to AI-native quality engineering on a banking platform, across 16 years.
- Organisation
- JPMorgan Chase, Deloitte and Medtronic
- My role
- Engineering and quality leader
- Period
- 2015 – 2026
The problem
Quality at scale depends on more than test tooling: practices that start early, shared automation standards, and clear ownership of whether a release is ready. In regulated domains such as medical devices and banking, that discipline matters even more.
My role
Across three organisations I moved from building automation frameworks to leading the organisations and governance around them:
- Medtronic: Software Engineering Lead, Test Automation for medical devices.
- Deloitte: from Consultant, Engineering Lead to Senior Specialist, Automation Solution Architect, to Specialist Master, Product Test Manager, promoted twice.
- JPMorgan Chase: Senior Vice President, Software Engineering, leading a team of 20+ engineers with P&L accountability for a $250K budget.
Approach and architecture
Regulated foundations. At Medtronic I engineered Console GUI and Therapy subsystem test frameworks on customised Android platforms, covering performance, security and BSP validation with Android CTS, and managed functional, integration and regression testing in Polarion. At Deloitte I set connected-device testing standards for a Class 2 SaMD product under IEC 62304 and designed iOS and Android BDD automation with Xamarin UI Test, SpecFlow and Xamarin Test Cloud.
Shift-left and shared standards. On a multi-million-dollar Deloitte product programme I introduced shift-left practices and BDD automation (Appium, Selenium, WebDriverIO), built and mentored the QA organisation, and set programme-wide test strategy, harness design and automation standards. Earlier, I defined a Gherkin/SpecFlow BDD strategy that aligned Dev and QA standards.
Clear ownership of readiness. I owned quality governance in PI Planning, defined the Definition of Done and gave final delivery sign-off together with Product and Engineering leadership.
AI-native quality. At JPMorgan Chase I extended this foundation with AI: an AI-native requirements platform and a CI/CD coverage agent, governed by LLM evaluation and responsible AI controls.
Evaluation and governance
Quality governance ran through every stage: IEC 62304 discipline in medical-device work, Definition of Done and delivery sign-off in PI Planning, and evaluation standards and responsible-AI controls for GenAI.
- 2015 – 2021
- Regulated foundationsMedical devices, IEC 62304
- 2016 – 2024
- Shift-left and BDDShared automation standards
- 2021 – 2024
- Quality governanceDefinition of Done, delivery sign-off
- 2024 – 2026
- AI-native qualityRAG, agents, LLM evaluation
Documented outcomes
- JPMorgan Chase: 60% shorter manual regression timelines, 15–20% faster developer turnaround and about $300K in annual savings.
- JPMorgan Chase: 93% end-to-end automation coverage in lower environments and 100% coverage of production scenarios, with zero P1/P2 defect leakage.
- Deloitte: pioneered the firm's first Class 2 Software as a Medical Device (SaMD) automation framework under IEC 62304.
- Deloitte: delivered 200 automated iOS and Android test cases at a 97% execution success rate.
Each outcome is shown with the role it was achieved in. JPMorgan Chase results are team-level results for that role.